Consumer Safety Considerations of Skin and Oral Microbiome Perturbation

DOI: 10.1128/CMR.00051-19

Article Information

DOI

PubMed

Published By

History

^aDivision of Pharmacy & Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, United Kingdom
^bDivision of Musculoskeletal & Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, United Kingdom
^cUnilever, Safety & Environmental Assurance Centre (SEAC), Sharnbrook, United Kingdom
^dDepartment of Microbiology, Immunology and Transplantation, Laboratory of Molecular Bacteriology, Rega Institute, Leuven, Belgium
^eDepartment CIBIO, University of Trento, Trento, Italy
^fDivision of Integrative Systems Medicine and Digestive Diseases, Imperial College London, London, United Kingdom
^gUnilever, Sharnbrook, United Kingdom
^hUnilever, Port Sunlight, United Kingdom
ⁱUnilever, Bangalore, India
^jUniversity of Tasmania, Hobart, Tasmania, Australia
^kPeriodontal Research Group, The University of Birmingham, Birmingham, United Kingdom
^lCentre for Host-Microbiome Interactions, King's College London, London, United Kingdom

Address correspondence to Andrew J. McBain, andrew.mcbain{at}manchester.ac.uk.
↵* Present address: Judith Fernandez-Piquer, Upfield, Rotterdam, The Netherlands.
Citation McBain AJ, O’Neill CA, Amezquita A, Price LJ, Faust K, Tett A, Segata N, Swann JR, Smith AM, Murphy B, Hoptroff M, James G, Reddy Y, Dasgupta A, Ross T, Chapple IL, Wade WG, Fernandez-Piquer J. 2019. Consumer safety considerations of skin and oral microbiome perturbation. Clin Microbiol Rev 32:e00051-19. https://doi.org/10.1128/CMR.00051-19.